These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38577532)

  • 1. Is there a need for universal double reflex testing of HBsAg-positive individuals for hepatitis D infection?
    Abbas Z; Abbas M
    World J Hepatol; 2024 Mar; 16(3):300-303. PubMed ID: 38577532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
    Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
    J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D.
    Palom A; Rando-Segura A; Vico J; Pacín B; Vargas E; Barreira-Díaz A; Rodríguez-Frías F; Riveiro-Barciela M; Esteban R; Buti M
    JHEP Rep; 2022 Oct; 4(10):100547. PubMed ID: 36052219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France.
    Parfut A; Tripon S; Gantner P; Chaffraix F; Laugel E; Wendling MJ; Erol F; Wiedemer C; Doffoel M; Saviano A; Royant M; Habersetzer F; Fafi-Kremer S; Velay A
    J Clin Virol; 2024 Apr; 171():105650. PubMed ID: 38350177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection.
    Cossiga V; Brusa S; Montalti R; De Conte A; Jannuzzi G; Ranieri L; Sorrentino R; Vallefuoco L; Pignata L; Guarino M; Portella G; Morisco F
    Liver Int; 2024 Jan; 44(1):148-154. PubMed ID: 37789576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hepatitis delta underestimated?
    Papatheodoridi M; Papatheodoridis GV
    Liver Int; 2021 Jun; 41 Suppl 1():38-44. PubMed ID: 34155795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis D virus among HBsAg-positive individuals, 2015-2016: Azar cohort study.
    Pouri AA; Ghojazadeh M; Baiaz B; Hamzavi FS; Pourasghari B; Somi MH
    Health Promot Perspect; 2020; 10(1):38-42. PubMed ID: 32104655
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnostic cascade for patients with hepatitis delta infection in France, 2018-2022: A cross-sectional study.
    Brichler S; Trimoulet P; Afonso AR; Izopet J; Thibault V; Roudot-Thoraval F; Chevaliez S
    Liver Int; 2024 Aug; ():. PubMed ID: 39115174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New epidemiology of hepatitis delta.
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2020 Feb; 40 Suppl 1():48-53. PubMed ID: 32077599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis.
    Buti M; Domínguez-Hernández R; Palom A; Esteban R; Casado MÁ
    Liver Int; 2023 Dec; 43(12):2611-2614. PubMed ID: 37916574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.
    Roggenbach I; Chi X; Lempp FA; Qu B; Walter L; Wu R; Gao X; Schnitzler P; Ding Y; Urban S; Niu J
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
    Lempp FA; Volz T; Cameroni E; Benigni F; Zhou J; Rosen LE; Noack J; Zatta F; Kaiser H; Bianchi S; Lombardo G; Jaconi S; Vincenzetti L; Imam H; Soriaga LB; Passini N; Belnap DM; Schulze A; Lütgehetmann M; Telenti A; Cathcart AL; Snell G; Purcell LA; Hebner CM; Urban S; Dandri M; Corti D; Schmid MA
    J Hepatol; 2023 Nov; 79(5):1129-1138. PubMed ID: 37459920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Slovakia Almost a Hepatitis D Free Country?
    Kristian P; Hockicková I; Hatalová E; Žilinčanová D; Rác M; Bednárová V; Lenártová PD; Dražilová S; Skladaný Ľ; Schréter I; Jarčuška P; Halánová M
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low seroprevalence of hepatitis delta virus co-infection in hepatitis B virus-infected blood donors in China: A multicenter study.
    Chang L; Yan Y; Ji H; Sun H; Jiang X; Lu Z; Wang L; Group HBDS
    Front Microbiol; 2022; 13():992817. PubMed ID: 36452933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Characteristics of Hepatitis Delta Virus Infection in a Tertiary Hospital Setting in Cameroon.
    Luma HN; Eloumou SAFB; Okalla C; Donfack-Sontsa O; Koumitana R; Malongue A; Nko'Ayissi GB; Noah DN
    J Clin Exp Hepatol; 2017 Dec; 7(4):334-339. PubMed ID: 29234199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination.
    de Los Ángeles Rodríguez Lay L; Tan Z; Villalba MCM; Suárez MS; Corredor MB; Hernández DL; Sánchez BM; Alonso LV; Sausy A; Hübschen JM
    Front Med (Lausanne); 2022; 9():1069372. PubMed ID: 36816726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan.
    Aftab M; Naz S; Aftab B; Ali A; Rafique S; Fatima Z; Inamullah ; Idrees M
    Viral Immunol; 2019 Oct; 32(8):335-340. PubMed ID: 31553269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.